CD91 and its ligand gp96 confer cross-priming capabilities to multiple APCs during immune responses to nascent, emerging tumors
Nayak, Devanshi A, Sedlacek, Abigail L, Cillo, Anthony R, Watkins, Simon C, Binder, Robert J
Published in Cancer immunology research (13.09.2024)
Published in Cancer immunology research (13.09.2024)
Get more information
Journal Article